SCHEMBL24461501

SCHEMBL24461501

Cc1ccccc1-c1cc2cc(C3CN(C(=O)OC(C)(C)C)C3)[nH]c2nn1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 2/20 0.42
▸ SMARCA4 P51532 2/20 0.42
▸ PBRM1 Q86U86 2/20 0.42
▸ CCNK O75909 1/20 0.41
▸ CDK12 Q9NYV4 1/20 0.41
▸ PIM1 P11309 5/20 0.41
▸ PIM2 Q9P1W9 5/20 0.41
▸ BACE1 P56817 3/20 0.39
▸ POLR1A O95602 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ HPGDS O60760 1/20 0.37
▸ NAMPT P43490 1/20 0.37
▸ PIK3CA P42336 2/20 0.37
▸ BACE2 Q9Y5Z0 1/20 0.36
▸ PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24461312 0.91 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL29619413 0.91 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL31505531 0.85 CCNT1 (0.41) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL29619389 0.79 KDM4E (0.40) CCNKCDK12BACE1KDM4ECCNT1
SCHEMBL24461328 0.79 KDM4E (0.40) CCNKCDK12BACE1KDM4ECCNT1
SCHEMBL24461358 0.78 PBRM1 (0.38) SMARCA2SMARCA4PBRM1
SCHEMBL24461456 0.77 PBRM1 (0.46) SMARCA2SMARCA4PBRM1CCNT1CDK9
SCHEMBL30658056 0.76 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL26654036 0.76 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CCNKCDK12
SCHEMBL30552692 0.75 PBRM1 (0.39) SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022109426-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2022-05-27 — — WO disclosed
Send feedback